Association Between Lymphotoxin Beta Receptor Gene Polymorphisms and IgA Nephropathy in Korean Children

REFERENCES

• Browning, J. L. (2008). Inhibition of the lymphotoxin pathway as a therapy for autoimmune disease. Immunol. Rev. 223:202–220.
   PubMed Web of Science ®Google Scholar
• Chang, Y. H., Hsieh, S. L., Chen, M. C., Lin, W. W. (2002). Lymphotoxin beta receptor induces interleukin 8 gene expression via NF-kappaB and AP-1 activation. Exp. Cell Res. 278(2):166–174.
   PubMedGoogle Scholar
• Coppo, R. (2008). Pediatric IgA nephropathy: clinical and therapeutic perspectives. Semin. Nephrol. 28(1):18–26.
   PubMedGoogle Scholar
• De Nardin, E. (2009). Genetic polymorphisms and immune responses. Immunol Invest. 38(3–4):198–202.
   PubMed Web of Science ®Google Scholar
• Gabriel, S. B., Schaffner, S. F., Nguyen, H., Moore, J. M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., Liu-Cordero, S. N., Rotimi, C., Adeyemo, A., Cooper, R., Ward, R., Lander, E. S., Daly, M. J., Altshuler, D. (2002). The structure of haplotype blocks in the human genome. Science 296(5576): 2225–2229.
   PubMed Web of Science ®Google Scholar
• Galla, J. H. (1995). IgA nephropathy. Kidney Int. 47(2):377–387.
   PubMed Web of Science ®Google Scholar
• Hahn, W. H., Cho, B. S., Kim, S. D., Kim, S. K., Kang, S. (2009). Interleukin-1 cluster gene polymorphisms in childhood IgA nephropathy. Pediatr. Nephrol. 24(7):1329–1336.
   PubMedGoogle Scholar
• Hsu, S. I., Ramirez, S. B., Winn, M. P., Bonventre, J. V., Owen, W. F. (2000). Evidence for genetic factors in the development and progression of IgA nephropathy. Kidney Int. 57(5):1818–1835.
   PubMedGoogle Scholar
• Hunley, T. E., Kon, V. (1999). IgA nephropathy. Curr. Opin. Pediatr. 11(2):152–157.
   PubMedGoogle Scholar
• Lim, T. W., Kim, S. K., Ban, J. Y., Chung, J.-H., Song, J. Y., Yoon, K. L., Park, S. W., Kim, K. S., Shin, O. Y. (2009). Polymorphisms of transmembrane channel-like 1 gene are associated with Kawasaki disease in Korean population. Mol. Cell. Toxicol. 5(4):291–297.
   Google Scholar
• Lim, Y. H., Jeong, Y. S., Kim, S. K., Kim, D. H., Yun, D. H., Yoo, S. D., Kim, H. S., Baik, H. H. (2011). Association between TGFBR2 gene polymorphism (rs2228048, Asn389Asn) and intracerebral hemorrhage in Korean population. Immunol Invest. 40(6):569–580.
   PubMed Web of Science ®Google Scholar
• Maruyama, K., Yoshida, M., Nishio, H., Shirakawa, T., Kawamura, T., Tanaka, R., Nakamura, H., Iijima, K., Yoshikawa, N. (2001). Polymorphisms of renin-angiotensin system genes in childhood IgA nephropathy. Pediatr. Nephrol. 16(4):350–355.
   PubMedGoogle Scholar
• McCarthy, D. D., Summers-Deluca L., Vu, F., Chiu, S., Gao, Y., Gommerman, J. L. (2006). The lymphotoxin pathway: beyond lymph node development. Immunol. Res. 35(1–2):41–54.
   PubMedGoogle Scholar
• Nakamura, T., Tashiro, K., Nazarea, M., Nakano T., Sasayama, S., Honjo, T. (1995). The murine lymphotoxin-beta receptor cDNA: isolation by the signal sequence trap and chromosomal mapping. Genomics 30(2): 312–319.
   PubMedGoogle Scholar
• Nakanishi, K., Sako, M., Yata, N., Aoyagi, N., Nozu, K., Tanaka, R., Iijima, K., Yoshikawa, N. (2004). A-20C angiotensinogen gene polymorphism and proteinuria in childhood IgA nephropathy. Pediatr. Nephrol. 19(2):144–147.
   PubMedGoogle Scholar
• Narita, I., Goto, S., Saito, N., Song, J., Kondo, D., Omori, K., Kawachi, H., Shimizu, F., Sakatsume, M., Ueno, M., Gejyo, F. (2003). Genetic polymorphism of NPHS1 modifies the clinical manifestations of IgA nephropathy. Lab. Invest. 83(8):1193–1200.
   PubMedGoogle Scholar
• Pettersson, E. (1997). IgA nephropathy: 30 years on. J. Intern. Med. 242(5):349–353.
   PubMedGoogle Scholar
• Schmidt, S., Ritz, E. (1999). Genetic factors in IgA nephropathy. Ann. Med. Intern. (Paris) 150(2):86–90.
   PubMedGoogle Scholar
• Scolari, F. (2003). Inherited forms of IgA nephropathy. J. Nephrol. 16(2):317–320.
   PubMedGoogle Scholar
• Tashiro, K., Tada, H., Heilker, R., Shirozu, M., Nakano, T., Honjo, T. (1993). Signal sequence trap: a cloning strategy for secreted proteins and type I membrane proteins. Science 261(5121):600–603.
   PubMedGoogle Scholar
• Tomino, Y. (2007). Pathogenesis of IgA nephropathy. Contrib. Nephrol. 157: 1–7.
   PubMed Web of Science ®Google Scholar
• Tumanov, A. V., Christiansen, P. A., Fu, Y. X. (2007). The role of lymphotoxin receptor signaling in diseases. Curr. Mol. Med. 7(6):567–578.
   PubMedGoogle Scholar
• Tumanov, A. V., Grivennikov, S. I., Shakhov, A. N., Rybtsov S. A., Koroleva, E. P., Takeda, J., Nedospasov, S. A., Kuprash, D. V. (2003). Dissecting the role of lymphotoxin in lymphoid organs by conditional targeting. Immunol. Rev. 195:106–106.
   PubMedGoogle Scholar
• Wang, J., Anders, R. A., Wu, Q., Peng, D., Cho, J. H., Sun, Y., Karaliukas, R., Kang, H. S., Turner, J. R., Fu, Y. X. (2004). Dysregulated LIGHT expression on T cells mediates intestinal inflammation and contributes to IgA nephropathy. J. Clin. Invest. 113(6):826–835.
   PubMed Web of Science ®Google Scholar
• Yoon, H. J., Shin, J. H., Yang, S. H., Cho, D. W., Kim, H., Lee, D. S., Kim, H. L., Kim, S., Lee, J. S., Kim, Y. S. (2003). Association of the CD14 gene-159C polymorphism with progression of IgA nephropathy. J. Med. Genet. 40(2):104–108.
   PubMedGoogle Scholar
• Yoshida, H., Mitarai, T., Kawamura, T., Kitajima, T., Miyazaki, Y., Nagasawa, R., Kawaguchi, Y., Kubo, H., Ichikawa, I., Sakai, O. (1995). Role of the deletion polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J. Clin. Invest. 96(5): 2162–2169.
   PubMedGoogle Scholar